Pregled bibliografske jedinice broj: 1017063
Epidemiology of Viperidae snake envenoming in central and southeastern Europe: CEE Viper Study
Epidemiology of Viperidae snake envenoming in central and southeastern Europe: CEE Viper Study // Clinical Toxicology
Napulj, Italija, 2019. str. 48-48 (poster, međunarodna recenzija, sažetak, znanstveni)
CROSBI ID: 1017063 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
Epidemiology of Viperidae snake envenoming in central and southeastern Europe: CEE Viper Study
Autori
Dobaja Borak, Mojca ; Babić, Željka ; Bekjarovski, Niko ; Cagáňová, Blažena ; Grenc, Damjan ; Gruzdyte, Laima ; Kabata, Piotr M ; Kastanje, Ruth ; Kolpach, Zuzana ; Krakowiak, Anna ; Pap, Csaba ; Radenkova-Saeva, Julia ; Sein-Anand, Jacek ; Vučinić, Slavica ; Zacharov, Sergey ; Eddleston, Michael ; Brvar, Miran
Vrsta, podvrsta i kategorija rada
Sažeci sa skupova, sažetak, znanstveni
Izvornik
Clinical Toxicology
/ - , 2019, 48-48
Skup
39th International Congress of the European Association of Poisons Centres and Clinical Toxicologists (EAPCCT 2019)
Mjesto i datum
Napulj, Italija, 21.05.2019. - 24.05.2019
Vrsta sudjelovanja
Poster
Vrsta recenzije
Međunarodna recenzija
Ključne riječi
Viperidae, envenoming, Europe
Sažetak
The study was a prospective multicentre survey of Viperidae snakebites and use of antivenoms in poison control centres and toxicology departments in Estonia, Lithuania, Poland, Czech Republic, Slovakia, Hungary, Slovenia, Croatia, Macedonia and Bulgaria. The incidence of Viperidae snakebites in central and south-eastern Europe is at least 2.9/million populations ; but is likely more, since not all snakebites would have been treated in toxicology departments or reported to local poison control centers. V. berus bites were most common, and although V. ammodytes bites had a higher median severity score it was not significant (2 compared to 1 for V. berus bites ; p = 0.18). Antivenom was used in half of the reported V. ammodytes bites (compared to 13% of V. berus bites). Three different antiViperidae antivenoms were used, none of which is European Medicines Agency (EMA)- approved. Only ViperaTab was used in both V. berus and V. ammodytes bites.
Izvorni jezik
Engleski
Znanstvena područja
Javno zdravstvo i zdravstvena zaštita
POVEZANOST RADA
Ustanove:
Institut za medicinska istraživanja i medicinu rada, Zagreb
Profili:
Željka Babić
(autor)
Citiraj ovu publikaciju:
Časopis indeksira:
- Current Contents Connect (CCC)
- Web of Science Core Collection (WoSCC)
- Science Citation Index Expanded (SCI-EXP)
- SCI-EXP, SSCI i/ili A&HCI
- Scopus
- MEDLINE